Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD: World’s leading Event Organizer

Conference Series LLC LTD Conferences gaining more Readers and Visitors

Conference Series LLC LTD Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

American Ophthalmology 2018

About Conference

Ophthalmology 2018 Scientific Committee is honoured to invite you all at the “ International Conference on Ophthalmology to be held in Atlanta, USA during July 16-17, 2018. The conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of ophthalmology which  include seminars, symposiums and workshops on the latest treatments and  innovations of various eye diseases, speeches delivered by Eminent Eye surgeons, Paediatric Ophthalmologist, General Ophthalmologist, Comprehensive Ophthalmologist. Retina Specialist, Retinal Surgeon, and many enthusiastic young researchers.

Conference Series LLC Ltd organizes 3000+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members

The discipline of Ophthalmology is concerned with correcting imperfections and treating conditions of the eye that are known to cause diminished or loss of vision. The eye, its surrounding structures and the visual system can be affected by a number of clinical conditions. Ophthalmology involves diagnosis and therapy of such conditions, along with microsurgery. Ophthalmologists have been on the leading edge of progress in diagnostic medicine, and they have developed some of the most effective medical and surgical treatments. The field of Ophthalmology is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Ophthalmology 2018 Congress maximizes the opportunity to interact with and learn from people from across the country and across the globe. This conference aimed at furnishing the resourceful and valuable information to the participants in the field of Ophthalmology. Ophthalmology 2018 will bring together the leading Ophthalmologic surgeon and scientists to discuss the practical challenges, concerns and strategies in this field, as well as promote collaborations and information exchange and share the new findings. It offers a great opportunity for Ophthalmologic physicians, clinicians and scientists, at any stage in their career, to present, develop their own technique, research, and network with other Ophthalmologic experts. The conference program covers a wide range of topics in basic research of Ophthalmology, advanced Ophthalmic diagnostic and treatment technology, Ophthalmic surgery, Eye diseases, Optometry and Vision science, Prevention and Clinical management  making the gathering a flawless stage to share emerging technology as well as the latest scientific knowledge, advancements, issues and challenges in the field of Ophthalmology.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentation

Poster Display

Symposium hosting (4-5 member team)


For Universities, Associations & Societies:

Association Partnering

Collaboration proposals

Academic Partnering

Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)

Young Researcher Forum (YRF Award to the best presenter)

Student Attendee

Group registrations

For Business Delegates:

Speaker Presentations

Symposium hosting

Book Launch event

Networking opportunities

Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths

Sponsorships opportunities

Product launch

Workshop organizing

Scientific Partnering

Marketing and Networking with clients


Common Eye Infections:

 The eye is well protected from infection by the conjunctiva and the corneal epithelium and also harbours a host of non-pathogenic bacteria that competitively prohibit new bacteria growth. However, these eye-defences can be breached by trauma, improper tearing, or contact lens wear and lead to an infection. An eye infection not only threatens vision, but the orbit can act as an entry portal to the rest of the body and infections can progress to systemic involvement, meningitis, and even death.

Age Related Macular Degeneration (ARMD).

Age Related Macular Degeneration is an important cause of Blindness / Visual handicap among the elderly. Age-related macular degeneration (AMD) is now one of the major causes of central vision loss. It involves the macular area and when it progresses and destroys the central fovea, quality of life is seriously compromised. The ability to read, drive, recognize faces or watch television is impaired or lost. It is a disease associated with aging and progressive tissue degeneration. AMD is, therefore, an active scientific area with new information becoming available almost every day on the pathophysiology, clinical phenotypes, and markers of disease progression, new treatments and novel treatment regimens.

Cataract and its treatment:

A Cataract is a clouding of the lens in the eye. Developing Cataracts will cause the sight to become cloudy and misty. Cataracts result from changes in the way the cells of the lens are arranged and their water content, which causes the lens to become cloudy instead of clear. A cataract is not a growth or a film growing over the eye; it is simply the lens becoming cloudy. Cataracts can affect one or both eyes and treated by surgery, during which the cloudy lens is removed and replaced by an artificial lens.

Paediatric Ophthalmology:

Paediatric ophthalmology is a sub-claim to fame of ophthalmology worried with eye ailments, visual improvement, and vision mind in youngsters. The Paediatric ophthalmologist has extra preparing, background, and skill in looking at youngsters, and has the best information of conceivable conditions that influence the paediatric patient and his/her eyes. Neurologic improvement of vision happens up until roughly age 12 years. Misalignment of the eyes (strabismus), uncorrected refractive blunder (nearsightedness, hyperopia, and astigmatism), and asymmetry of refractive mistake between the two eyes can adversely influence this advancement.

Errors of Refraction and Refractive surgery:

Refractive errors are vision problems that happen when the eye does not refract (bend) light properly. Uncorrected refractive error is the single most critical eye care issue around the world and the most easily addressed cause of vision loss. One effective way to eliminate this leading cause of vision loss is to improve the delivery of refractive eye care and provide spectacles to those in significant need. Refractive surgery corrects the eye’s refractive errors to improve vision.


Neuro-ophthalmology is the joining of neurology and ophthalmology, regularly managing complex systemic maladies that have indications in the visual framework. Cerebral Visual Impairment incorporates every visual brokenness brought on by harm to, or breaking down of the Retrochiasmetic visual pathways without harm to the front visual pathways or any significant visual sickness. Myasthenia gravis is created by a breakdown in the typical correspondence amongst nerves and muscles which prompts twofold vision, hanging eyelids and different muscles shortcoming which affecting the both i.e. neuromuscular action furthermore vision. Then again nystagmus which is automatic eye development procured in outset or sometime down the road that may bring about decreased or constrained vision. Components like cerebral macular degeneration and perpetual dynamic outside ophthalmoplegia additionally the major affecting a portion of Neuro-ophthalmology. Symptomatic instruments in Neuro-ophthalmology are utilized to explore and to treat the different state of Neuro-ophthalmology as Neonatal visual examination are essentially performed to screen the nearness and movement of Retinopathy of Prematurity. 

Optometric Vision Therapy:

Optometric Vision therapy is visual training or orthoptics is an individualized treatment program designed to improve overall visual function and performance. Its proven results are derived from vision-based neurological and neuromuscular conditioning over time. Many functional vision problems can be significantly improved through optometric vision therapy.

Ophthalmic Drug Delivery

Ophthalmic drug delivery is one of the interesting and challenging endeavours facing the pharmaceutical scientists. Most ocular diseases are treated by topical drug application in the form of solutions, suspensions, ointment and other drug delivery devices like inserts, implants, gelling systems, etc. These conventional and novel dosage forms suffer from the problems of poor ocular bioavailability, because of various anatomical and pathophysiological barriers prevailing in the eye.

Contact Lens and Its Complications

Contact lenses have been developed for more than a hundred years and progresses in Contactology are spectacular. The evolution of knowledge in corneal and ocular surface physiology led in parallel to considerable progress concerning contact lenses, allowing distribution of optical correction and therapy in a large population and of all ages. Eye care practitioners are responsible for recommending contact lenses taking into account all the factors involved, try to develop with caution the indications for optical correction and therapeutic with soft contact lenses, especially silicone hydrogel. New challenges and perspectives emerged from progress in performance of these lenses by avoiding hypoxia.

Diabetic Microvascular Complications

Diabetes and related complications are associated with long‑term damage and failure of various organ systems. The line of demarcation between the pathogenic mechanisms of microvascular and macro vascular complications of diabetes and differing responses to therapeutic interventions is blurred. Diabetes induces changes in the microvasculature, causing extracellular matrix protein synthesis, and capillary basement membrane thickening which are the pathognomic features of diabetic microangiopathy. Diabetic retinopathy may be the most common microvascular complication of diabetes. The risk of developing diabetic retinopathy or other microvascular complications of diabetes depends on both the duration and the severity of hyperglycemia.

Cornea and Corneal Disorders:

The Cornea is a transparent exterior part of the eye that covers the iris, pupil, and foremost chamber. The cornea, with the front chamber and lens, refracts light, with the cornea representing around 66% of the eye's aggregate optical force. Corneal diseases, for example, corneal ulceration, epithelial keratitis and drug-induced epithelial keratitis, corneal degeneration, repetitive corneal disintegration and different corneal issue can influence the cornea and at last prompt the external eye disease that could wind up with perpetual visual impairment.

Retinal Disorders and Surgery:

The Retina is a layer of tissue present in the interior of your eye. Retinal disorders are mainly due to lack of light-delicate cells and other nerve cells which transform the impulse into visual information. Retina sends this visual data to the cerebrum through your optic nerve and process the information into an image and empowering you to see. Different age group generations, races and ethnicities are effected from Retinal degenerative disorders, for instance, Age-related macular degeneration and myopic macular degeneration.


Uveitis is caused by disorders of diverse etiologies including wide spectrum of infectious and non-infectious causes. The inflammatory process primarily affects the uveal tissues with subsequent damage to the retina, optic nerve and vitreous. On several occasions, it reflects diseases that are developing elsewhere in the body and uveitis may be the first evidence of such systemic diseases, generating a challenge for the ophthalmologist in reaching correct diagnosis.

Clinical and Surgical Ophthalmology

Clinical and Surgical Ophthalmology will upgrade your insight into normal visual infections, ophthalmic surgical and laser methodology, clinical life systems and visual therapeutics. You will create explanatory abilities for taking care of clinical case issues and assessing distributed research, and increase important research involvement through the open door. Clinical Ophthalmology will enhance thought into typical visual sicknesses, ophthalmic surgical and laser strategy, clinical life structures and visual therapeutics. Patients with eye infections get inspected by Ophthalmologists and Optometrists.


Glaucoma is an eye disease where the optic nerve dies that gradually steals the vision. Damage to the optic nerve is the common end result of all glaucomas. Usually, glaucoma has no symptoms in its early stages. Without proper treatment, glaucoma can lead to blindness. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible.



Market Analysis

Ophthalmology 2018 Market research:

The market for prescription ophthalmological therapeutics will experience considerable and consistent growth throughout the next 10 years as demographic changes and lifestyle factors drive the need for developing safe and effective therapies for eye disorders.

Although the overall ophthalmological market—projected to be about $19 billion for all pharmaceutical, consumer, and surgical products that come into direct contact with the eyes.

For the entire U.S. ophthalmological prescription drug market, a compound annual growth rate of 15% is projected for the 2007–2010 period, with the compound annual growth rate flattening to 10% or less during the following 5–10 years (Figure).

The ophthalmology market is primarily driven by age- and lifestyle-related diseases including age-related macular degeneration and glaucoma, which affects only 1 in 200 people under age 50. Diabetic retinopathy is linked to type 2 diabetes and as type 2 diabetes spreads among the under-50 population, the incidence of diabetic retinopathy will increase. The number of people with impaired vision, including blindness, living in the U.S. will at least double over the next three decades. About 119 million Americans are older than 40, which is the age at which serious eye diseases typically become a problem. Some 35 million are already affected by the four most prevalent: age-related macular degeneration, diabetic retinopathy, glaucoma, and cataracts, although cataract treatment is confined to surgery rather than therapeutics.

With over 23,861 Ophthalmologist in the United States (American Medical Association) the demand for eye care procedures vs. those professional performing them is running short.  Eye care procedures and the demand for care are growing at an alarming pace.  The World Health Organization estimates that there are 285 million individuals that are currently suffering from visual impairment.  65% of those individuals are over the age of 50.  Of those, 246 million suffers from low vision issues and another 39 million people are legally blind.  The United States alone, eye disease is predicted to affect at least 50 million people within the next 15 years.  Blindness and impaired vision is predicted to double by the year 2040.


To Collaborate Scientific Professionals around the World

Conference Date July 16-17, 2018

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Journal of Clinical & Experimental Ophthalmology Optometry: Open Access Journal of Eye Diseases and Disorders International Journal of Ophthalmic Pathology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner